WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4601 Infant (under 12 months) mortality rate: 792
GDP / capita (US$): 1'0691 Child (under 5 years) mortality rate: 1262

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 11'451  11'162  10'876  10'593  10'315  8'746  6'020  4'495 
Births 428  422  416  410  404  369  287  215 
Surviving infants 396  390  384  377  371  330  248  180 
Pop. less than 5 years 1'856  1'823  1'784  1'748  1'714  1'511  1'076  776 
Pop. less than 15 years 4'870  4'766  4'659  4'560  4'460  3'851  2'638  1'875 
Female 15-49 years 2'662  2'586  2'513  2'439  2'366  1'983  1'359  1'057 

Number of reported case

(Click for retrospective incidence data for Guinea)
Diphtheria 37 
Japanese encephalitis
Measles 11  45  264  89  11'294  12'756  8'552 
Mumps
Pertussis 25  247  412  2'315 
Polio* 43  155  32 
Rubella 55  34  88 
Rubella (CRS)
Tetanus (neonatal) 17  64  21  28  245  53 
Tetanus (total) 64  54  28  245  524  482 
Yellow fever 445 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea)
Vaccine year result method % card seen                                                
BCG 2011  82  DHS/MICS     84  93  93  93  92  71  50 
DTP1 2011  76  DHS/MICS     99*  80  95  89  80  67 
DTP3 2011  50  DHS/MICS     99*  85  90  85  70  57  20 
HepB_BD         
HepB3 2011  50  DHS/MICS     99*  85  90  85  70 
Hib3 2011  50  DHS/MICS     99*  85  90  85 
JapEnc         
MCV 2011  62  DHS/MICS     99*  90  90  87  90  59  25 
MCV2         
PCV1         
PCV3         
Pol3 2011  51  DHS/MICS     97  85  90  90  90  57  20 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  85  EPI   75.0  86  80  70  82  85  43  21 
PAB         
VAD1          80  100  90  97  64 
YFV 2011  38  DHS/MICS     99*  90  90  71  90 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea)
BCG 84  93  93  91  87  81  50 
DTP1 86  86  86  76  64  61  40 
DTP3 59  59  64  57  60  46  17 
HepB3 59  59  64  57  57 
Hib3 59  59  64  57 
MCV 58  58  58  53  55  42  35 
PAB 80  80  90  96  96  79  27 
PCV3
Pol3 57  57  62  60  59  47  18 
Rota_last
YFV 56  56  56  52  47 

Number of districts in the country 38  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 68
From 80 to 89% 29
From 50 to 79% 3
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHep 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1 month; Yes
VitaminA 6, 12 months; Yes 6-59 months
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011- 2015  2007-2011  2007-2011  2007-2011  2007-2011  2006 - 2010 
Nº of districts with microplans that include activities to raise immunization coverage number 38  38  38  38  38  38  38 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 38  38  38  38  38  38  38 
Nº districts with DTP3 coverage >=80% number 37  33  27  24  25  32  26 
% of districts with DTP3 coverage >=80% From 0 to 100% 97  87  71  63  66  84  68 
Nº districts with measles (MCV1) coverage >=95% number 18  21  10     
% of districts with MCV1 coverage >=95% From 0 to 100% 47  55  26  16  18     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 24  24  30  65  70  40 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.